Open AccessMolgramostim (GM-CSF) Associated With Antibiotic Treatment in Nontraumatic Abdominal Sepsis
Author(s) -
Héctor Orozco
Publication year - 2006
Publication title -
archives of surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-3644
pISSN - 0004-0010
DOI - 10.1001/archsurg.141.2.150
Subject(s) - medicine , sepsis , antibiotics , surgery , adverse effect , placebo , metronidazole , white blood cell , amikacin , gastroenterology , microbiology and biotechnology , biology , alternative medicine , pathology
The addition of molgramostim (recombinant human granulocyte-macrophage colony-stimulating factor) to antibiotic therapy for nontraumatic and generalized abdominal sepsis is effective and has a significant impact on length of hospitalization, direct medical costs, and mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom